Literature DB >> 22890524

[Laboratory diagnostics for early detection of rheumatic autoimmune diseases: a guide for the general practitioner].

Georg Endler1, Ulrike Demel, Ernst Forster, Andrea Griesmacher, Christin Hübner, Werner Klotz, Günter Steiner, W Wagner, Manfred Herold.   

Abstract

Autoimmune diseases are a clinically heterogeneous group of disorders that represent a challenge for the general practitioner in daily routine. Except for rheumatoid arthritis, which is one of the most frequent autoimmune diseases with a prevalence of approximately 1 % of the population, systemic autoimmune disorders are rare. Thus outside specialized wards it might be a challenge to diagnose the underlying autoimmune disease considering the often kaleidoscopic clinical manifestations. Together with careful anamnesis and suspicious clinical symptoms determination of specific autoantibodies can support the suspected diagnosis. The Austrian group of the European autoimmune standardization initiative (EASI) firstly published this guide 2009 with the aim to provide a map through the jungle of the biomarkers for autoimmune diseases for the general practitioner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890524     DOI: 10.1007/s10354-012-0134-8

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  26 in total

Review 1.  Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice.

Authors:  N Bizzaro; A Wiik
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

2.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

3.  European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders.

Authors:  A Wiik; R Cervera; M Haass; C Kallenberg; M Khamashta; P L Meroni; J-C Piette; R Schmitt; Y Shoenfeld
Journal:  Lupus       Date:  2006       Impact factor: 2.911

4.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

Review 5.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

6.  Clinical and serological heterogeneity in patients with anticentromere antibodies.

Authors:  Shoji Miyawaki; Hiroko Asanuma; Susumu Nishiyama; Yasuhiko Yoshinaga
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

Review 7.  The epidemiology of autoimmune diseases.

Authors:  Glinda S Cooper; Berrit C Stroehla
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

Review 8.  Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations.

Authors:  Theodore Pincus; Tuulikki Sokka
Journal:  Rheum Dis Clin North Am       Date:  2009-11       Impact factor: 2.670

Review 9.  Mechanisms of autoimmunity.

Authors:  Noel R Rose
Journal:  Semin Liver Dis       Date:  2002-11       Impact factor: 6.115

10.  Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus.

Authors:  D A Hesselink; L A Aarden; A J G Swaak
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.